QR-koodi

Early Initiation of rhGH Therapy Significantly Improves Height Gain and Reduces the Gap to Target Height in Children Born Small for Gestational Age: A Multicenter Retrospective Study

<b>Background</b>: Treatment with recombinant human growth hormone (rhGH) is approved for children born small for gestational age (SGA) who fail to show postnatal catch-up growth; however, optimizing its efficacy remains a challenge. <b>Aim</b>: to evaluate the impact of rhGH therapy on growth traje...

Täydet tiedot

Tallennettuna:
Päätekijät: Letteria Anna Morabito, Malgorzata Wasniewska, Cecilia Lugarà, Emanuela Pignatone, Domenico Corica, Renato Vaiasuso, Alessandra Cipriani, Giovanni Luppino, Roberto Coco, Giorgia Pepe, Tiziana Abbate, Stefano Stagi, Tommaso Aversa
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI AG 2026-05-01
Sarja:Children
Aiheet:
small for gestational age
growth trajectory
height gain
adult height
recombinant human growth hormone
Linkit:https://www.mdpi.com/2227-9067/13/5/641
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia